Elevance Health (ELV) Return on Capital Employed (2009 - 2026)

Elevance Health (ELV) has 18 years of Return on Capital Employed data on file, last reported at 3.02% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 3.02%, up 15.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.02% (up 15.0% YoY), and the FY2025 annual result was 2.81%, down 3.0% from the prior year.
• Return on Capital Employed rose to 3.02% in Q1 2026 per ELV's latest filing, from 2.71% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 13.77% in Q1 2022 and troughed at 2.29% in Q2 2023.
• A 5-year average of 4.47% and a median of 2.8% in 2025 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed soared 1215 bps in 2022, then slumped 989 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 12.58% in 2022, then plunged by 79 bps to 2.69% in 2023, then advanced by 0 bps to 2.69% in 2024, then gained by 0 bps to 2.71% in 2025, then advanced by 12 bps to 3.02% in 2026.
• Business Quant data shows ELV's Return on Capital Employed at 3.02% in Q1 2026, 2.71% in Q4 2025, and 2.73% in Q3 2025.